Cargando…

Lipidized PrRP Analog Exhibits Strong Anti-Obesity and Antidiabetic Properties in Old WKY Rats with Obesity and Glucose Intolerance

Prolactin-releasing peptide (PrRP) is an anorexigenic neuropeptide that has potential for the treatment of obesity and its complications. Recently, we designed a palmitoylated PrRP31 analog (palm(11)-PrRP31) that is more stable than the natural peptide and able to act centrally after peripheral admi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mráziková, Lucia, Hojná, Silvie, Vaculová, Petra, Strnad, Štěpán, Vrkoslav, Vladimír, Pelantová, Helena, Kuzma, Marek, Železná, Blanka, Kuneš, Jaroslav, Maletínská, Lenka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864151/ https://www.ncbi.nlm.nih.gov/pubmed/36678151 http://dx.doi.org/10.3390/nu15020280

Ejemplares similares

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances
por: Mráziková, Lucia, et al.
Publicado: (2022)

Metabolomic Study of Aging in fa/fa Rats: Multiplatform Urine and Serum Analysis
por: Pelantová, Helena, et al.
Publicado: (2023)

Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice
por: Mengr, Anna, et al.
Publicado: (2023)

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models
por: Mráziková, Lucia, et al.
Publicado: (2021)

Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity
por: Pražienková, Veronika, et al.
Publicado: (2017)

NPFFR2-deficient mice fed a high-fat diet develop strong intolerance to glucose
por: Karnošová, Alena, et al.
Publicado: (2023)

Age-related metabolic and neurodegenerative changes in SAMP8 mice
por: Pačesová, Andrea, et al.
Publicado: (2022)

Physiological Roles of GPR10 and PrRP Signaling
por: Dodd, Garron T., et al.
Publicado: (2013)

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells
por: Zmeškalová, Anna, et al.
Publicado: (2020)

Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study
por: Karnošová, Alena, et al.
Publicado: (2021)

Echinoderms provide missing link in the evolution of PrRP/sNPF-type neuropeptide signalling
por: Yañez-Guerra, Luis Alfonso, et al.
Publicado: (2020)

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22
por: Kacířová, Miroslava, et al.
Publicado: (2021)

Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study
por: Mikulášková, Barbora, et al.
Publicado: (2018)

The Medial Amygdala-Medullary PrRP-Synthesizing Neuron Pathway Mediates Neuroendocrine Responses to Contextual Conditioned Fear in Male Rodents
por: Yoshida, Masahide, et al.
Publicado: (2014)

Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats
por: Špolcová, Andrea, et al.
Publicado: (2014)

Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides
por: Kořínková, L., et al.
Publicado: (2020)

Lipidated PrRP31 metabolites are long acting dual GPR10 and NPFF2 receptor agonists with potent body weight lowering effect
por: Alexopoulou, Flora, et al.
Publicado: (2022)

Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice
por: Maletínská, Lenka, et al.
Publicado: (2008)

The Development of Hypertension in Rats with Intraventricular Grafts of Fetal SHR or WKY Hypothalamus
por: Murphy, C. A., et al.
Publicado: (1992)

Testosterone influences renal electrolyte excretion in SHR/y and WKY males
por: Toot, Jonathan, et al.
Publicado: (2008)

Functional and neurometabolic asymmetry in SHR and WKY rats following vasoactive treatments
por: Segarra, Ana B., et al.
Publicado: (2019)

Categorizing SHR and WKY rats by chi2 algorithm and decision tree
por: Tsai, Ping-Rui, et al.
Publicado: (2021)

Antidiabetes and Anti-obesity Activity of Lagerstroemia speciosa
por: Klein, Guy, et al.
Publicado: (2007)

Behavioral variability, elimination of responses, and delay-of-reinforcement gradients in SHR and WKY rats
por: Johansen, Espen B, et al.
Publicado: (2007)

Prolactin-Releasing Peptide: Physiological and Pharmacological Properties
por: Pražienková, Veronika, et al.
Publicado: (2019)

Intestinal Ralstonia pickettii augments glucose intolerance in obesity
por: Udayappan, Shanthadevi D., et al.
Publicado: (2017)

The RNA ligands for mouse proline-rich RNA-binding protein (mouse Prrp) contain two consensus sequences in separate loop structure
por: Hori, Tamaki, et al.
Publicado: (2005)

Expression of certain cerebrospinal fluid proteins in hydrocephalus and aging. A study on WKY rats
por: Gonzalez-Marrero, Ibrahim, et al.
Publicado: (2006)

Age-Related Alterations in Endothelial Function of Femoral Artery in Young SHR and WKY Rats
por: Puzserova, Angelika, et al.
Publicado: (2014)

Fetal programming of adrenal PNMT and hypertension by glucocorticoids in WKY rats is dose and sex-dependent
por: Khurana, Sandhya, et al.
Publicado: (2019)

ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats
por: Kozłowska, Anna, et al.
Publicado: (2019)

COVID-19-related school closing aggravate obesity and glucose intolerance in pediatric patients with obesity
por: Kim, Eun Sil, et al.
Publicado: (2021)

Intergenerational Transmission of Glucose Intolerance and Obesity by In Utero Undernutrition in Mice
por: Jimenez-Chillaron, Josep C., et al.
Publicado: (2009)

Correction: Intestinal Ralstonia pickettii augments glucose intolerance in obesity
Publicado: (2018)

Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains
por: Mill, Jonathan, et al.
Publicado: (2005)

Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients
por: Chey, William, et al.
Publicado: (2020)

Serotonin transporter deficiency drives estrogen-dependent obesity and glucose intolerance
por: Zha, Weibin, et al.
Publicado: (2017)

Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance
por: Dai, Wen, et al.
Publicado: (2021)

Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice
por: Uchida, Akihiro, et al.
Publicado: (2021)

Dieting reverses histone methylation and hypothalamic AgRP regulation in obese rats
por: Rapps, Kayla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cs1dkq3kgbaof1affrf6i24tcm